Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer
{{output}}
Discoidin domain receptor 2 (DDR2) is arising as a promising therapeutic target in breast carcinoma (BC). The ability of DDR2 to bind to collagen promotes protumoral responses in cancer cells that influence the tumor microenvironment (TME). Nonetheless, the in... ...
